Krucker Thomas, Schuler Alexandra, Meyer Eric P, Staufenbiel Matthias, Beckmann Nicolau
Department of Neuropharmacology, Scripps Research Institute, La Jolla, CA, USA.
Neurol Res. 2004 Jul;26(5):507-16. doi: 10.1179/016164104225016281.
In vivo imaging technologies are presently receiving considerable attention in the biomedical and pharmaceutical research areas. One of the principal imaging modalities is magnetic resonance imaging (MRI). The multiparametric nature of MRI enables anatomical, functional and even molecular information to be obtained non-invasively from intact organisms at high spatial resolution. Here we describe the use of one MRI modality, namely angiography (MRA), to non-invasively study the arterial vascular architecture of APP23 transgenic mice modeling Alzheimer's disease. Because the spatial resolution of the technique is limited, the in vivo studies are complemented by a powerful analysis of the vasculature using vascular corrosion casting. Both techniques revealed age-dependent blood flow alterations and cerebrovascular abnormalities in these mice. Our experience suggests that MRA complemented by cast analysis are important tools to describe vascular alterations and test new therapy concepts in animal models of AD. Furthermore, being non-invasive, MRA can also be applied to studies in patients suffering from this disease.
体内成像技术目前在生物医学和制药研究领域受到了广泛关注。主要的成像方式之一是磁共振成像(MRI)。MRI的多参数特性使得能够在高空间分辨率下从完整生物体中无创地获取解剖学、功能甚至分子信息。在此,我们描述了使用一种MRI方式,即血管造影(MRA),来无创研究模拟阿尔茨海默病的APP23转基因小鼠的动脉血管结构。由于该技术的空间分辨率有限,体内研究通过使用血管铸型对脉管系统进行强大分析来补充。两种技术都揭示了这些小鼠中与年龄相关的血流改变和脑血管异常。我们的经验表明,由铸型分析补充的MRA是描述血管改变和在AD动物模型中测试新治疗概念的重要工具。此外,由于MRA是非侵入性的,它也可应用于对患有这种疾病的患者的研究。